Current Rating and Its Significance
MarketsMOJO currently assigns Asarfi Hospital Ltd a 'Buy' rating, indicating a positive outlook for the stock based on a comprehensive evaluation of its quality, valuation, financial trend, and technical indicators. This rating suggests that the stock is expected to deliver favourable returns relative to its peers and the broader market, making it a suitable consideration for investors seeking growth opportunities within the hospital sector.
Quality Assessment
As of 05 January 2026, Asarfi Hospital Ltd holds an average quality grade. This reflects a stable operational foundation with consistent earnings growth and manageable debt levels. The company demonstrates a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.44 times, which indicates prudent financial management and reduced risk of solvency issues. Furthermore, the company has declared very positive results in the September 2025 quarter, marking two consecutive quarters of robust performance. Profit Before Tax (PBT) excluding other income reached ₹4.89 crores, growing by 122.3% compared to the previous four-quarter average, while net sales hit a record ₹44.89 crores. These factors contribute to the company’s solid quality profile.
Valuation Perspective
The valuation grade for Asarfi Hospital Ltd is currently attractive. The company’s Return on Capital Employed (ROCE) stands at 8.6%, which, combined with an Enterprise Value to Capital Employed ratio of 3.2, suggests that the stock is reasonably priced relative to the capital it utilises to generate profits. Additionally, the Price/Earnings to Growth (PEG) ratio is an exceptionally low 0.2, signalling that the stock’s price does not fully reflect its earnings growth potential. This valuation metric is particularly compelling for investors looking for undervalued opportunities with strong growth prospects.
Register here to know the latest call on Asarfi Hospital Ltd
- - Fundamental Analysis
- - Technical Signals
- - Peer Comparison
Financial Trend and Performance
The financial trend for Asarfi Hospital Ltd is rated very positive as of 05 January 2026. The company has demonstrated impressive growth in profitability, with net profit increasing by 34.38% in the latest quarter. Over the past year, profits have surged by 161%, underscoring the company’s strong earnings momentum. The stock has delivered a remarkable 91.35% return over the last 12 months, significantly outperforming the broader market benchmark, the BSE500, which returned just 5.35% during the same period. This market-beating performance highlights the company’s ability to generate shareholder value consistently.
Technical Outlook
From a technical standpoint, Asarfi Hospital Ltd maintains a bullish grade. The stock’s price movements over recent months reflect positive momentum, with a 3-month return of 39.26% and a 6-month return of 32.86%. Despite a slight 5.76% decline over the past month, the overall trend remains upward, supported by strong volume and investor interest. The technical indicators suggest that the stock is well-positioned for continued gains, reinforcing the 'Buy' rating.
Summary for Investors
Investors considering Asarfi Hospital Ltd should note that the 'Buy' rating reflects a balanced view of the company’s current fundamentals and market position. The average quality grade indicates stable operations, while the attractive valuation metrics suggest the stock is reasonably priced relative to its growth potential. The very positive financial trend and bullish technical outlook further support the case for investment. Together, these factors imply that Asarfi Hospital Ltd offers a compelling opportunity for investors seeking exposure to the hospital sector with a microcap profile and strong growth characteristics.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Key Metrics at a Glance (As of 05 January 2026)
Market Capitalisation: Microcap segment
Mojo Score: 77.0 (Buy Grade)
Debt to EBITDA Ratio: 1.44 times
Net Profit Growth (Latest Quarter): 34.38%
PBT (Excluding Other Income, Latest Quarter): ₹4.89 crores (122.3% growth vs previous 4Q average)
Net Sales (Latest Quarter): ₹44.89 crores (highest recorded)
PBDIT (Latest Quarter): ₹8.87 crores (highest recorded)
ROCE: 8.6%
Enterprise Value to Capital Employed: 3.2
PEG Ratio: 0.2
1-Year Stock Return: +91.35%
BSE500 1-Year Return Benchmark: +5.35%
Conclusion
Asarfi Hospital Ltd’s current 'Buy' rating by MarketsMOJO reflects a well-rounded assessment of its operational quality, attractive valuation, strong financial growth, and positive technical signals. While the company’s quality grade is average, its financial performance and valuation metrics provide a compelling investment case. The stock’s significant outperformance relative to the broader market further underscores its appeal. Investors should consider these factors carefully when evaluating Asarfi Hospital Ltd as part of their portfolio strategy.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
